Summary
The development of T cells from stem (progenitor) cells to effector cells results from a two-wave process of proliferation and differentiation. The cells of the first differentiation wave are the precursor T cells, and those of the second differentiation wave are peripheral T cells. In the first differentiation wave, resting/circulating naive antigen-reactive T lymphocytes are produced which differ from each other in their antigen receptor-specificity. In the second differentiation wave, those T lymphocytes multiply whose antigen receptors have found the corresponding antigen. Thus three major forms of differentiation can be distinguished in the peripheral T cells: (1) resting/circulating naive antigen-reactive T cells, (2) activated T cells, and (3) effector T cells and memory T cells. In addition, there are at least three major organ-restricted sublines of peripheral T cells, i.e., nodal T cells, mucosa-associated T cells, and skin-associated T cells. Thanks to the availability of markers for most of the above-mentioned T-cell sublines and differentiation forms, all these cellular forms can be associated with certain lymphoma types, i.e., lymphomas of T-cell type can be divided into categories of precursor T-cell lymphomas and peripheral T-cell lymphomas. The peripheral T-cell lymphomas can be subdivided into those derived from lymph nodal, mucosal, and cutaneous T cells. The gut mucosal T-cell lymphomas are associated with enteropathy. The lymph node, mucosal, and cutaneous T-cell lymphomas can be further subdivided into those in which all tumor cells are similar to recirculating resting (nonactivated) T cells, those in which some of the tumor cells resemble activated T cells, and those in which all tumor cells resemble activated T cells. The second group includes pleomorphic T-cell lymphoma, Lennert’s lymphoma, and angioimmunoblastic T-cell lymphoma, and the third group includes Ki-1+ (CD30+) anaplastic large-cell (ALC) lymphomas of T-cell type. The apparently constant association of Ki-1+ T-ALC lymphoma with the breakpoint 5q35 underlines the justification of its classification as a separate entity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Janossy G, Grant-Prentice H. T-cell subpopulations, monoclonal antibodies and their therapeutic applications. Clin Haematol 1982; 11: 631–660.
Foon KA. Todd RF 3d. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31.
Stein H, Mason DY, Gerdes J, O’Conner N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K. The expression of the Hodgkin’s disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue.–Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858.
Stein H, Gerdes J. Phänotypische and genotypische Marker bei malignen Lymphomen. Ein Beitrag zum zellulären Ursprung des Morbus Hodgkin and der malignen Histiozytose sowie Implikationen für die Klassifikation der T-Zell and B-ZellLymphome. Verh. Dtsch. Ges. Path. 1986; 70: 127–151.
Stein H, Dallenbach F, Dienemann D. Differenzierungslinien physiologischer and maligner Zellen des lymphatischen Systems. Verh Dtsch Ges Pathol 1988; 72: 57–85.
Suchi T, Lennert K, Tu LY, Kikuchi M, Sato E, Stansfeld AG, Feller AC. Histopathology and immunohistochemistry of peripheral T-cell lymphomas: a proposal for their classification. J Clin Pathol 1987; 40: 995.
Stansfeld AG, Diebold J, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundström C, van Unnik JAM, Wright DH. Updated Kiel Classification for lymphomas. Lancet 1988; is 292–293.
Picker LJ, Weiss LM, Medeiros LJ, Wood GS, Warnke RA. Immunophenotypic criteria for the diagnosis of non-Hodgkin’s lymphoma. Am J Pathol 1987; 128: 181–201.
Said JW, Shintaku IP, Parekh K, Pinkus GS. Specific phenotyping of T cell proliferations in formol-fixed paraffin-embedded tissues: Use of antibodies to the T cell receptor ßF1. Am J Clin Pathol 1990; 93: 382–386.
Delsol G, Al Saati T, Gatter KC, Gerdes J, Schwarting R, Caveriviere P, Rigal-Huguet F, Robert A, Stein H, Mason DY. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Am J Pathol 1988; 130: 59–70.
Isaacson PG, Spencer J, Connolly CE, Pollock DJ, Stein H, O’Conner NTJ, Bevan DH, Kirkham N, Wainscoat JS, MaSON DY. Malignant histiocytosis of the intestine: A T cell lymphoma. Lancet 1985; ii: 688–691.
Weiss LM, Trela MJ, Cleary ML, Turner RR, Warnke RA, Sklar E. Frequent immunoglobulin and T cell receptor gene rearrangements in `histiocytic’ neoplasms. Am J Pathol 1985; 121: 369–373.
Beljaards RC, Meijer CJLM, Scheffer E, Toonstra J, van vloten WA, van der Putte SCJ, Geerts ML, Willemze R. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large cell lymphomas of T origin: a clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 1989; 135: 1169–1178.
Engelhard M, von Schilling C, Diehl V, Pfreundschuh M, Brittinger G, Feller AC, Stein H, Zwingers T, Lennert K. Clinical analysis of Ki-1 lymphoma. Blut 1986; 53: 220 (abstract).
Engelhard M, von Schilling C, Diehl V, Pfreundschuh M, Brittinger G, Zwingers T, Feller AC, Stein H, Lennert K. CD30 (Ki-1)’ lymphoma: morphological and immunohistological characterization, identification of three subentities, and clinical analysis of 92 cases. Blood 1990; (submitted).
Kaudewitz P, Stein H, Dallenbach F, Eckert F, Bieber K, Burg G, Braun-Falco O. Primary and secondary Cuntaneous Ki-1 (CD30’) Anaplastic Large Cell Lymphomas. Morphologic, Immunohistologic, and Clinical Characteristics. Am J Pathol 1989; 135: 359–367.
Morgan R, Hecht BK, Sandberg AA, Hecht F, Smith SD. Chromosome 5q35 breakpoint in malignant histiocytosis. N Eng J Med 1986; 314: 1322 (Letter).
Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristoffersson U, Magaud JP, Nezelof C, Tilly H, Vanier JP, Hemet J, Warnke R. CD30-positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35. Brit J Haematol 1990; 74: 161–168.
Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW. Morphology in Ki-1 (CD30)-positive non-Hodgkin’s lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2; 5) (p23; q35). Am J Surg Pathol 1990; 14: 305–316.
Fairley NH, Mackiew FP. Clinical and biochemical syndrome in lymphadenoma and allied diseases involving mesenteric lymph glands. Brit Med J 1937; 1: 375–380.
Isaacson PG, Wright DH. Malignant histiocytosis of the intestine: its relationship to malabsorption and ulcerative jejunitis. Hum Pathol 1978; 9: 661–677.
Guy-Grand D, Griscelli C, Vassali P. The mouse gut T lymphocyte, a noval type of T cell: Nature, origin, and traffic in mice in normal graft-versus-host conditions. J Exp Med 1978; 148: 1661–1677.
Cerf-Bensussan N, Jarry A, Brousse N, Lisowska-Grospierre B, Guy-Grand D, Griscelli C. A monoclonal antibody (HML1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol 1987; 17: 1279–1285.
Spencer J, Cerf-Bensussan N, Jarry A, Brousse N, Guy-Grand D, Krajewski AS, Isaacson PG. Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 1988; 132: 1–5.
Stein H, Dienemann D, Sperling M, Zeitz M, Riecken EO. Identification of a T cell lymphoma category derived from intestinal mucosa-associated T cells. Lancet 1988; ii: 10531954.
Visser L, Shaw A, Slupsky J, Vos H, Poppema S. Monoclonal antibodies reactive with hairy cell leukemia. Blood 1989; 74: 320–325.
Kruschwitz M, Fritzsche G, Schwarting R, Micklem K, Mason DY, Falini B, Stein H. Ber-ACT8: A new monoclonal antibody defining a trimeric antigen associated with activated CD8 T cells, gut mucosa T cells, and hairy cell leukemia cells (submitted).
Schwarting R, Dienemann D, Kruschwitz M, Fritzsche G, Stein H. Specificities of monoclonal antibodies B-1y7 and HML-1 are identical. Blood 1990; 320.
Sperling M, Kaudewitz P, Braun-Falco O, Stein H. Reactivity of T cells in mycosis fungoides exhibiting marked epidermotropism with the monoclonal antibody HML-1 that defines a membrane molecule on human mucosal lymphocytes. 1989, Amer J Path 1989; 134: 955–960.
Picker LJ, Michie SA, Rott LS, Butcher EC. A unique phenotype of skin-associated lymphocytes in human: Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990; 136: 1053–1068.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Stein, H., Dienemann, D., Dallenbach, F., Kruschwitz, M. (1991). Peripheral T-cell lymphomas. In: Ultmann, J.E., Samuels, B.L. (eds) Annals of Oncology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7305-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7305-4_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7294-1
Online ISBN: 978-1-4899-7305-4
eBook Packages: Springer Book Archive